BioNTech SE (BSP:B1NT34) Dividends per Share : R$0.00 (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is BioNTech SE Dividends per Share?

BioNTech SE's dividends per share for the three months ended in Sep. 2024 was R$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2024 was R$0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, BioNTech SE's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

BioNTech SE Dividends per Share Historical Data

The historical data trend for BioNTech SE's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Dividends per Share Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

0.74

BioNTech SE Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BioNTech SE's Dividends per Share

For the Biotechnology subindustry, BioNTech SE's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNTech SE's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where BioNTech SE's Dividend Yield % falls into.

BioNTech SE Dividends per Share Calculation

Dividends paid to per common share.

BioNTech SE (BSP:B1NT34) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

BioNTech SE's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2024 )	/	EPS without NRI (Q: Sep. 2024 )
	=	0	/	0.311
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 8 years, the highest Dividend Yield of BioNTech SE was 2.18%. The lowest was 0.00%. And the median was 0.00%.

BioNTech SE Dividends per Share Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (BSP:B1NT34) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

BNTX:USA BNTX:Mexico 0A3M:UK 22UA:Germany 22UA:Bulgaria BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

BioNTech SE Headlines

No Headlines